Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DUKADA is a Danish medical device and digital health company that develops smart add-ons for injection pens. Its core products include DUKADA Sense, a connected smart cap that captures dose timing and size and transmits data to digital health platforms, and DUKADA Trio, a timer cap with user-support features for insulin pen users. The company sells primarily business-to-business to pharmaceutical companies and injection pen manufacturers, offering customizable smart cap solutions for disposable and reusable pens. While rooted in diabetes care, DUKADA has expanded its positioning to support broader self-injection categories such as growth hormone, fertility, and weight management. The business is best characterized as a commercial medtech platform company focused on connected care for pen-based injectable therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DUKADA.